Every other asset class treats a rate hike as a discount-rate problem. Private credit is the one $2tn pool where it's a cash-flow problem for the borrower and an earnings windfall for the lender — arriving on different clocks. That gap is the trade.
Kevin Warsh's first Jackson Hole speech moved September hike odds from ~35% to 46–56% and the 2-year to 4.325%. Consensus reads that as bad for private credit. That is half right, and it's the useless half.
A hike is immediately accretive to the earnings of every BDC whose loans still pay cash — roughly +13% net investment income per 100bp — and eventually fatal to the borrowers of every BDC whose loans already don't. The market prices the sector as one undifferentiated fear. It isn't one thing.
Highest-conviction call: buy OBDC at $10.90–11.40 for $13.00, and sell it into the Q4 earnings beat rather than holding it for yield. The earnings upgrade arrives next quarter; the credit damage arrives three to six quarters later. Own the first, be gone before the second.
Warsh delivered his first Jackson Hole keynote, In Our Time, on his 100th day as Chair. The quoted line was the hawkish tell: "We must be confident that underlying inflation is moving to our objective, clearly and at sufficient speed. Otherwise, we have work to do."
The passage that matters more came four paragraphs earlier, and I haven't seen anyone pick it up:
Warsh cited tight credit spreads, heavy leveraged-loan issuance, and easy bank lending standards as evidence that policy is not restrictive — "credit and loan markets are showing few signs of policy restraint," and he'd be "hard pressed to describe broad financial conditions as restrictive."
Read that as a lender. Private credit raised $190bn in the first half, up 53% year over year, at compressing spreads, into a record 6.1% default rate. The asset class's own capital formation is now an input to the reaction function that will impair it. Private credit is arguing for its own rate hike. That reflexivity is unpriced, and it's why I think the hike lands by December rather than not at all.
The inflation number that decides this: PCE is running 3.7% over twelve months but 4.1% over six. Six-month above twelve-month is the arithmetic definition of reacceleration. Warsh pre-empted the "it's just the oil shock" rebuttal himself — 54% of the 199 PCE components rose more than 3%, against a 32% pre-pandemic norm. That's a breadth problem, and breadth problems get solved with the funds rate, not patience. (Full disaggregation, Appendix C.)
My probabilities: ~25% September, ~60% cumulative by December, ~15% no hike through Q1'27.
The S&P closed down just 0.25%. Underneath it, the Russell 2000 fell 1.40% — and the long bond rallied while the 2-year sold off 9bp. That combination is the whole story in two data points: the market believes Warsh will hike, and believes hiking restores credibility. Maximum pain concentrated at the front end, where every floating-rate loan in the private credit book resets. Minimum pain for duration. (Full cross-asset table, Appendix A.)
Here is the mechanism, stripped to two numbers.
The lender gains. OBDC holds 96% floating-rate assets against a liability stack that is majority fixed-coupon notes issued in 2021–22. A 100bp hike adds roughly +$0.19 per share of net investment income — 13% earnings accretion — on a stock trading at 0.79x book.
The borrower loses. The same 100bp costs a 6.5x-levered sponsor borrower about 6.5% of EBITDA. A 7.5x borrower goes from 1.42x interest coverage today to 1.17x after 200bp — below the ~1.25x line where sponsors stop writing equity cheques and start negotiating PIK. And per KBRA, 27% of private credit borrowers were already below 1.0x coverage in 2024. (Both models with full assumptions, Appendix B.)
Net the two, and a line falls out:
A 100bp hike pays for itself unless it raises your non-accrual rate by more than roughly 2 percentage points of the gross book.
The sector median non-accrual rate is 2.8% of cost. So half the sector is on the wrong side of a line nobody has drawn — because the market is sorting these names on discount-to-NAV, which tells you nothing about rate sensitivity.
| Name | Price | P/NAV | Non-accruals | Verdict on +100bp |
|---|---|---|---|---|
| OBDC | $11.30 | 0.79x | 0.8% at fair value | Clearly accretive — non-accruals would need to near-triple to break even |
| ARCC | $19.91 | 1.03x | 2.4% at cost | Accretive, but zero valuation cushion |
| BXSL | $24.90 | 0.98x | 1.8% at fair value | Accretive; cleanest book, weakest dividend coverage |
| FSK | $12.25 | 0.67x | 7.1% at cost | Destructive — that 7.1% earns nothing from the hike |
| TCPC | $4.13 | 0.71x | 7.4% at cost | Destructive; a sale-process security, not a rate security |
The asymmetry in one line: a non-accrual loan is the only asset in a BDC that captures 0% of the rate benefit and 100% of the recovery risk. FSK's 33% discount is not a margin of safety — it is a correct price. (Per-name fundamentals, Appendix D.)
The consensus model is Fed → defaults → NAV, which takes years. The faster channel takes quarters and almost nobody models it.
Push the 1-year bill from 4.13% toward 4.60% and you have compressed the illiquidity premium on a gated ~9% non-traded product by ~50bp for zero incremental risk. That decision is already going the wrong way: Q2 redemption requests hit 12.4% of NAV — the highest ever recorded — with only 38% fulfilled and a $9.6bn backlog. Non-traded fundraising fell 82% year over year.
A gated fund that must raise cash sells into a secondary market clearing at ~90 cents on the manager's own marks. Every forced sale installs another rung on a real, observable price curve. That is how a rate hike marks down a book that hasn't defaulted.
Which resolves an anomaly I've been tracking: OBDC trades at 0.79x NAV while BCRED, OCIC and OTIC all transact at exactly 1.000x — same platforms, same seniority. A 21-point gap closes one of two ways. Until today I gave decent odds to "listed goes up." A hiking Fed shifts the weight toward "non-traded marks come down." (Redemption and secondary-pricing data, Appendix E.)
| Call | Entry | Target | Invalidation | Horizon | Conviction |
|---|---|---|---|---|---|
| LONG OBDC | $10.90–11.40 | $13.00 0.91x NAV = the 90c clearing price | Q3 NAV below $13.75, or fair-value non-accruals above 2.0% (from 0.8%), at the early-Nov report | 1–3 months | HIGH |
| SHORT / AVOID FSK | $12.00–12.60 | $10.25 ~0.56x NAV | Weekly close above $13.50, or non-accruals at cost below 5.0% at Q3 | 1–3 months | HIGH |
| SHORT ARES | $141–148 | $120 | Weekly close above $155, or any direct-lending LBO above $2bn announced | 1–3 months | SPECULATIVE |
On OBDC — why two independent signals, not one. First, the mechanics above. Second, insider behaviour: every single Form 4 filed on OBDC in the last twelve months is a purchase. Zero sales. The CEO bought 41,600 shares at $11.75; a director bought at $11.21 as recently as May. The people who read the actual loan tapes have been buying this exact price for nine months.
On the OBDC exit discipline, which matters more than the entry: this is a two-quarter trade, not a yield position. The Q4 print will read "BDC beats on higher rates." That headline is your sell signal, not your confirmation.
On ARES — why I'm labelling my own idea speculative. One signal supports it: direct lenders have not financed an LBO above $2bn since March, which throttles fee-earning AUM growth, and these stocks are priced on the growth rate, not the level. Two signals oppose it: Oppenheimer raised its target to $162 yesterday, and the chart is a bull flag near highs. I'm publishing the level, not sizing it like the BDC pair.
Stated plainly, because a thesis without this is just a narrative:
One prior call, marked to market: yesterday I flagged trimming high-duration software into this speech, on the grounds that VIX near 14.5 meant essentially no volatility insurance was priced into the year's most consequential Fed event. It resolved hawkish and high-duration risk underperformed a flat SPY. Re-entry zones unchanged: CRM $215–225, CRWD $200–210.
All prices my own pulls at approximately 12:00 ET, Friday August 28, 2026.
| Instrument | Level | Change | Read |
|---|---|---|---|
| 3-month T-bill | 3.835% | +6.1 bp | — |
| 6-month | 3.995% | +8.8 bp | — |
| 1-year | 4.126% | +10.4 bp | Biggest move on the curve |
| 2-year | 4.325% | +9.3 bp | One-month high; ~57bp above the funds upper bound |
| 10-year | 4.708% | +3.6 bp | Barely moved |
| 30-year | ~5.16–5.19% | flat to −3 bp | Rallied on hawkishness = credibility restored |
| Fed funds target | 3.50–3.75% | unchanged at July FOMC | — |
| DXY | 99.55 | +0.4% | Confirms the rate read |
September hike odds: 46% per CME FedWatch via Reuters, 55.7% per CNBC, captured at different points in the session; ~35% Thursday.
| Instrument | Price | Change |
|---|---|---|
| S&P 500 / SPY | 7,711.76 / 771.09 | −0.25% |
| Nasdaq Composite / QQQ | 26,402.42 / 717.93 | −0.52% / −0.44% |
| Russell 2000 / IWM | 2,972.37 / 296.61 | −1.40% / −1.07% |
| VIX | ~14.5 | YTD intraday low 14.1 |
| XLF | 58.30 | +0.73% |
| BDCs | ||
| OBDC | 11.30 | +0.18% |
| FSK | 12.25 | — |
| ARCC | 19.91 | — |
| BXSL | 24.90 | — |
| GBDC | 13.02 | −0.38% |
| MAIN | 58.76 | — |
| HTGC | 17.56 | — |
| TCPC | 4.13 | — |
| PSEC | 2.28 | — |
| Alternative managers | ||
| APO | 135.66 | +1.66% |
| ARES | 142.79 | +0.27% |
| BX | 144.66 | +0.71% |
| KKR | 110.92 | +1.46% |
| BLK | 1,177.41 | +0.84% |
| Crypto | ||
| BTC | 78,478 | −2.30% |
| Crypto Fear & Greed | 73 (Greed) | — |
Note the alt managers rose on a hawkish day — higher rates help their insurance and annuity spread businesses. That's a genuine offset and it's why the ARES short is labelled speculative rather than high conviction.
Inputs, from OBDC's June 30, 2026 results: NAV $14.26/share; net leverage 1.11x; weighted average yield on debt investments 9.9%; spread over base ~5.6%; 96% of assets floating rate.
Derived per share: total assets ≈ $30.09 (NAV $14.26 + debt $15.83); floating assets ≈ $28.90.
Key assumption: ~40% of the debt stack floats (revolver and SPV facilities), ~60% is fixed-coupon unsecured notes issued in the 2021–22 window. This is the assumption most worth challenging — sensitivity is roughly ±$0.02/share per 100bp for every 10 percentage points of mix.
| Base-rate move | Gross income Δ | Interest expense Δ | Net NII Δ post ~17.5% incentive fee | % of $1.44 annualised NII |
|---|---|---|---|---|
| +25 bp | +$0.072 | −$0.016 | +$0.047 | +3.3% |
| +50 bp | +$0.145 | −$0.032 | +$0.093 | +6.5% |
| +100 bp | +$0.289 | −$0.063 | +$0.186 | +12.9% |
Context: the base dividend runs $1.24/year annualised and was covered 109% last quarter. An extra $0.19 is 15% of incremental dividend headroom.
Inputs: SOFR ~3.75%, typical direct lending spread ~560bp, all-in coupon ~9.35%. Coverage = 1 ÷ (leverage × coupon). Assumes no EBITDA growth and no addback normalisation — both of which would make the picture worse, not better.
| Debt / EBITDA | Today | +100 bp | +200 bp |
|---|---|---|---|
| 6.0x | 1.78x | 1.61x | 1.46x |
| 6.5x | 1.64x | 1.48x | 1.35x |
| 7.5x | 1.42x | 1.29x | 1.17x |
| 8.5x | 1.26x | 1.14x | 1.03x |
Below ~1.25x is where sponsors stop injecting equity and start negotiating. The escalation order, per Benefit Street's Anant Kumar: maturity extension → PIK → sponsor cheque → covenant relief. His framing: "the fourth amendment on the same name is not a bridge to recovery, it's deferral."
At a 65% recovery assumption, each incremental 1.0pp of the gross book going permanently non-accrual costs:
Set against +$0.186/share of NII from a 100bp hike: +$0.186 ÷ $0.105 ≈ 1.8, call it ~2 percentage points of incremental permanent non-accrual before the hike stops paying for itself.
Where this could be wrong: the 65% recovery assumption is the load-bearing input. At 50% recovery the break-even tightens to ~1.3pp and more of the sector falls on the wrong side. At 80% it widens to ~3.5pp and only the genuinely impaired books fail.
From "In Our Time," Chairman Kevin Warsh, Jackson Hole, August 28, 2026. Read in full at federalreserve.gov.
"We must be confident that underlying inflation is moving to our objective, clearly and at sufficient speed. Otherwise, we have work to do."
"I stand here today committed to a discipline, not to a decision."
"Credit spreads on corporate bonds and leveraged loans are near the low ends of their historical ranges, and issuance volumes in these markets have been quite strong this year. Looking beyond fixed-income markets to the banking business, in the July Senior Loan Officer Opinion Survey on Bank Lending Practices, banks tell us that standards for commercial and industrial loans are on the easier end of their historical range. That helps explain the growth we've seen this year in those loans. Credit and loan markets are showing few signs of policy restraint."
"Certain sectors — like housing and agriculture — are showing strains. But, on balance, I would be hard pressed to describe broad financial conditions as restrictive."
Fifth principle: short-term interest rates are the predominant tool. Sixth principle: "money matters… We should pay attention to money created by the central bank and money that comes from the banking and financial systems."
Annex Wealth's Brian Jacobsen flagged the live scenario: Warsh may push to stop expanding the balance sheet before hiking, potentially producing the first Chair-in-the-minority dissent since Eccles in 1939.
| Metric | OBDC | ARCC | BXSL | FSK |
|---|---|---|---|---|
| Price (8/28) | $11.30 | $19.91 | $24.90 | $12.25 |
| Forward P/E | 9.40 | 11.16 | 10.34 | 317.8 (meaningless) |
| Dividend yield | 10.66% | 9.65% | — | 12.86% |
| ROE | 3.95% | 6.78% | 4.78% | −6.7% |
| TTM EPS | — | — | — | −$1.34 |
| Revenue YoY | — | — | — | −20.1% |
| Beta | 0.71 | — | 0.45 | — |
| Market cap | $5.90bn | $14.5bn | — | — |
| 52-week range | $10.52–14.44 | — | — | $9.72–18.25 |
| Non-accruals | 0.8% FV / 2.8% cost | 2.4% cost | 1.8% FV | 7.1% cost / 3.8% FV |
Sell-side markers: JP Morgan holds FSK at neutral with an $11 target raised August 19 — below the current $12.25. Oppenheimer raised ARES to $162 on August 27.
Every filing is a purchase. There are no sales in the record.
| Date | Insider | Shares | Price |
|---|---|---|---|
| Nov 18, 2025 | Craig Packer (CEO) | 41,600 | $11.75 |
| Feb 27, 2026 | Logan Nicholson | 4,475 + 5,525 | $11.32 |
| May 11, 2026 | Eric Kaye | 1,000 | $11.21 |
| Jun 2, 2026 | Logan Nicholson | 400 + 2,600 | $11.31 |
For comparison, ARCC insiders bought a cluster in February 2026 at $19.13–19.29: Markowicz 15,000, Schnabel 12,500, Lem 5,186, Henson 4,000.
~90 cents on the manager's own marks, for a diligenced first-lien direct lending book. Established by Pantheon's August 4 purchase out of BlackRock TCP Capital — headline 95% of December 31 gross fair value, but CFO Erik Cuellar put the effective discount at "about 10%" on the call, 10.4% including expenses. Corroborated by LP-led credit secondaries printing 90–92% of NAV through 2026. Measure every discount against 90, not against par and not against 95.
| Vehicle | Price / NAV | AUM | Distribution rate |
|---|---|---|---|
| OBDC (listed) | 0.79x | $5.9bn cap | 10.66% |
| BCRED (non-traded) | 1.000x | $77.2bn | 9.1% |
| OCIC (non-traded) | 1.000x | $35.8bn | 9.25% |
| OTIC (non-traded) | 1.000x | ~$5bn | 9.28% |
Monthly NAV trajectory worth tracking, because it shows a sign flip between 2025 and 2026 — consistent with AI impairing the legacy software loan book:
| Jan 25 | Dec 25 | Mar 26 | Jun 26 | Jul 26 | FY25 | 2026 YTD | |
|---|---|---|---|---|---|---|---|
| OTIC | 10.43 | 10.38 | 9.82 | 9.70 | 9.67 | −0.48% | −6.84% |
| OCIC | 9.54 | 9.32 | 9.08 | 9.05 | 9.07 | −2.31% | −2.68% |
Apollo, Ares, Blackstone, Blue Owl and KKR don't eat the loan losses — their limited partners do. What they eat is deployment. Fee-related earnings are a function of fee-earning AUM, and fee-earning AUM growth requires deployment, not just fundraising. Apollo posted record Q2 FRE of $785m, +25% YoY at a 58.5% margin — but that describes a Q1–Q2 environment. With no >$2bn direct-lending LBO since March, the FRE growth rate is what compresses, and these stocks are priced on the growth rate.
Levels: ARES below $120 or APO below $118 is where the market stops paying for FRE growth and starts paying for FRE.
The marginal funding for middle-market private credit is CLO liabilities. TCPC demonstrated in August that the retained equity of a middle-market CLO issued in May 2026 could transfer within ten weeks at a price implying ~28% loss on that equity. Widen CLO liability spreads with balance-sheet runoff on top and you remove the cheapest leverage in the system: BDC returns on equity fall structurally, originations slow, and new-money loan spreads finally widen — resolving the spread anomaly, but in 2027, not 2026.
Affirm's CEO noted the national average gasoline price at $4.09/gallon, last below $3.00 on March 2. Consumer-services and retail-adjacent private credit borrowers face rising input costs, weak pricing power and a rising coupon simultaneously — Kumar's "operating costs and financing costs rise but revenue fails to keep pace."
| Asset class | Read-through | Regime-changing level |
|---|---|---|
| Rates | Bear-flattening: front end sold off, long end rallied. The market believes Warsh hikes and that hiking restores credibility — maximum pain for floating-rate borrowers, minimum for duration. | 2Y > 4.50%; 2s30s inside +70bp |
| Small-cap equity | IWM −1.07% vs a flat SPY is the cleanest daily read on floating-rate corporate leverage. Small caps and private credit borrowers share a balance-sheet profile; only one of them discloses it daily. | IWM < $290 |
| Alt-manager equity | Rose on the day because a hike helps insurance and annuity spread businesses. A real offset, and the reason the ARES short stays speculative. | ARES < $120, APO < $118 |
| Gold / Bitcoin | Gold near $4,660/oz — its best month since 1999 — rallying alongside hawkish signals points to a genuine policy-error hedge rather than a rate-cut trade. BTC at $78,478 (−2.3%) with Fear & Greed at 73 gave some back; the debasement bid is real but not immune to a front-end repricing. | GLD < $400, or 10Y sustained < 4.30% for two weeks |
The BDC sector traded at ~0.83x book in September 2015 and ~0.81x at the January 2016 trough on energy-driven credit stress, recovering to ~1.00x by August 2016. Today's sector multiple is comparable. Two differences cut in opposite directions:
Argues for a faster recovery: in 2015–16 the problem was concentrated, identifiable and commodity-priced — energy loans marked against an observable oil strip. Price discovery was fast, so recovery was fast.
Argues against: today's problem is software and business services — borrowers underwritten at 6–8x ARR or EBITDA in 2020–21, whose end markets are being disintermediated by AI, and whose loans have no observable price at all. And the 2015–16 recovery happened while the Fed hiked once in fifteen months into a disinflationary world. This time the Fed would be hiking into 4.1% six-month core PCE.
Analysis, not investment advice. Levels and probabilities reflect my own judgment as of August 28, 2026. Where a figure is my estimate or calculation, the assumptions are stated in Appendix B so you can disagree with them precisely. I publish updates when the data changes, and corrections when I'm wrong.